Bg Medicine Inc (BGMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,566 | 2,787 | 4,073 | 2,815 | 1,634 |
| Cost of Goods | 505 | 956 | 1,389 | 957 | 619 |
| Gross Profit | 1,061 | 1,831 | 2,684 | 1,858 | 1,015 |
| Operating Expenses | 6,196 | 10,149 | 17,447 | 25,543 | 19,119 |
| Operating Income | -4,630 | -7,362 | -14,374 | -22,728 | -17,485 |
| Interest Expense | 159 | 728 | 1,168 | 1,083 | 89 |
| Other Income | -514 | 26 | -307 | 42 | -8 |
| Pre-tax Income | -5,303 | -8,064 | -15,849 | -23,769 | -17,582 |
| Net Income Continuous | -5,303 | -8,064 | -15,849 | -23,769 | -17,582 |
| Net Income | $-5,303 | $-8,064 | $-15,849 | $-23,769 | $-17,582 |
| EPS Basic Total Ops | -0.72 | -0.99 | -2.33 | -4.72 | -4.00 |
| EPS Basic Continuous Ops | -0.55 | -0.99 | -2.33 | -4.70 | -3.99 |
| EPS Diluted Total Ops | -0.72 | -0.99 | -2.33 | -4.72 | -4.00 |
| EPS Diluted Continuous Ops | -0.55 | -0.99 | -2.33 | -4.70 | -3.99 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -1.00 | -2.32 | -4.72 | -4.00 |
| EBITDA(a) | $-4,543 | $-7,231 | $-14,209 | $-22,455 | $-17,065 |